Dr. Lal PathLabs Statistics
Total Valuation
Dr. Lal PathLabs has a market cap or net worth of INR 281.46 billion. The enterprise value is 274.86 billion.
Market Cap | 281.46B |
Enterprise Value | 274.86B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | Aug 20, 2024 |
Share Statistics
Dr. Lal PathLabs has 83.31 million shares outstanding. The number of shares has increased by 0.11% in one year.
Shares Outstanding | 83.31M |
Shares Change (YoY) | +0.11% |
Shares Change (QoQ) | -0.13% |
Owned by Insiders (%) | 55.56% |
Owned by Institutions (%) | 27.84% |
Float | 36.73M |
Valuation Ratios
The trailing PE ratio is 73.75 and the forward PE ratio is 62.26. Dr. Lal PathLabs's PEG ratio is 3.81.
PE Ratio | 73.75 |
Forward PE | 62.26 |
PS Ratio | 12.28 |
PB Ratio | 15.20 |
P/FCF Ratio | n/a |
PEG Ratio | 3.81 |
Enterprise Valuation
EV / Earnings | 72.04 |
EV / Sales | 12.02 |
EV / EBITDA | 43.72 |
EV / EBIT | 55.83 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 13.10 |
Debt / EBITDA | 0.39 |
Debt / FCF | n/a |
Interest Coverage | 18.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 14.48% |
Revenue Per Employee | 5.58M |
Profits Per Employee | 930,800 |
Employee Count | 4,099 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.87% in the last 52 weeks. The beta is 0.32, so Dr. Lal PathLabs's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | +50.87% |
50-Day Moving Average | 3,128.09 |
200-Day Moving Average | 2,632.74 |
Relative Strength Index (RSI) | 64.85 |
Average Volume (20 Days) | 214,157 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Lal PathLabs had revenue of INR 22.88 billion and earned 3.82 billion in profits. Earnings per share was 45.81.
Revenue | 22.88B |
Gross Profit | 13.22B |
Operating Income | 4.92B |
Pretax Income | 5.38B |
Net Income | 3.82B |
EBITDA | 5.91B |
EBIT | 4.92B |
Earnings Per Share (EPS) | 45.81 |
Balance Sheet
The company has 9.43 billion in cash and 2.47 billion in debt, giving a net cash position of 6.96 billion or 83.50 per share.
Cash & Cash Equivalents | 9.43B |
Total Debt | 2.47B |
Net Cash | 6.96B |
Net Cash Per Share | 83.50 |
Equity (Book Value) | 18.85B |
Book Value Per Share | 222.23 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 57.78%, with operating and profit margins of 21.52% and 16.68%.
Gross Margin | 57.78% |
Operating Margin | 21.52% |
Pretax Margin | 23.51% |
Profit Margin | 16.68% |
EBITDA Margin | 25.83% |
EBIT Margin | 21.52% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.71%.
Dividend Per Share | 24.00 |
Dividend Yield | 0.71% |
Dividend Growth (YoY) | 100.00% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.11% |
Shareholder Yield | 0.60% |
Earnings Yield | 1.36% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |